搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Streptococcus pyogenes serotype M12 GTPase Era (era) CSB-YP628184SAAV
CSB-EP628184SAAV
CSB-BP628184SAAV
CSB-MP628184SAAV
CSB-EP628184SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 Ribosome-recycling factor (frr) CSB-YP628185SAAV
CSB-EP628185SAAV
CSB-BP628185SAAV
CSB-MP628185SAAV
CSB-EP628185SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP628186SAAV
CSB-EP628186SAAV
CSB-BP628186SAAV
CSB-MP628186SAAV
CSB-EP628186SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 Transcriptional repressor NrdR (nrdR) CSB-YP628187SAAV
CSB-EP628187SAAV
CSB-BP628187SAAV
CSB-MP628187SAAV
CSB-EP628187SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 Methionine import ATP-binding protein MetN (metN) CSB-YP628188SAAV
CSB-EP628188SAAV
CSB-BP628188SAAV
CSB-MP628188SAAV
CSB-EP628188SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 Glycerol-3-phosphate dehydrogenase [NAD (P)+] (gpsA) CSB-YP628189SAAV
CSB-EP628189SAAV
CSB-BP628189SAAV
CSB-MP628189SAAV
CSB-EP628189SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 Acetate kinase (ackA) CSB-YP628190SAAV
CSB-EP628190SAAV
CSB-BP628190SAAV
CSB-MP628190SAAV
CSB-EP628190SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 30S ribosomal protein S5 (rpsE) CSB-YP628191SAAV
CSB-EP628191SAAV
CSB-BP628191SAAV
CSB-MP628191SAAV
CSB-EP628191SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 50S ribosomal protein L24 (rplX) CSB-YP628192SAAV
CSB-EP628192SAAV
CSB-BP628192SAAV
CSB-MP628192SAAV
CSB-EP628192SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 50S ribosomal protein L23 (rplW) CSB-YP628193SAAV
CSB-EP628193SAAV
CSB-BP628193SAAV
CSB-MP628193SAAV
CSB-EP628193SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 DNA repair protein recO (recO) CSB-YP628194SAAV
CSB-EP628194SAAV
CSB-BP628194SAAV
CSB-MP628194SAAV
CSB-EP628194SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine D-2-hydroxyglutarate dehydrogenase, mitochondrial (D2HGDH), partial CSB-YP628195BO
CSB-EP628195BO
CSB-BP628195BO
CSB-MP628195BO
CSB-EP628195BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Xaa-Pro aminopeptidase 1 (XPNPEP1), partial CSB-YP628196BO
CSB-EP628196BO
CSB-BP628196BO
CSB-MP628196BO
CSB-EP628196BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Polycomb group RING finger protein 5-B (pcgf5b) CSB-YP628197DIL
CSB-EP628197DIL
CSB-BP628197DIL
CSB-MP628197DIL
CSB-EP628197DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Shadow of prion protein (sprn) CSB-YP628198DIL
CSB-EP628198DIL
CSB-BP628198DIL
CSB-MP628198DIL
CSB-EP628198DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Solute carrier family 35 member E3 (slc35e3), partial CSB-YP628199DIL
CSB-EP628199DIL
CSB-BP628199DIL
CSB-MP628199DIL
CSB-EP628199DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine E3 ubiquitin-protein ligase E3D (UBE3D) CSB-YP628200BO
CSB-EP628200BO
CSB-BP628200BO
CSB-MP628200BO
CSB-EP628200BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine NAD-dependent protein deacetylase sirtuin-4 (SIRT4) CSB-YP628201BO
CSB-EP628201BO
CSB-BP628201BO
CSB-MP628201BO
CSB-EP628201BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Probable RNA polymerase II nuclear localization protein SLC7A6OS (SLC7A6OS) CSB-YP628202BO
CSB-EP628202BO
CSB-BP628202BO
CSB-MP628202BO
CSB-EP628202BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Eukaryotic translation initiation factor 3 subunit A (Eif3a), partial CSB-YP628203RA
CSB-EP628203RA
CSB-BP628203RA
CSB-MP628203RA
CSB-EP628203RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>